Internal Medicine, Endocrinology, Diabetes, & Metabolism · Mission Viejo, CA
NPI
1235116542
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
26800 Crown Valley Pkwy Ste 230
Mission Viejo, CA, 92691
Phone (949) 542-8004
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
9,336 services
Medicare patients, 2024
307
Average age 75
Drug cost, 2024
$594K
1,908 prescriptions
Company payments, 2025
$1,676
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mim I Mulford was code 99214 (office e&m - established), 552 times for 281 patients. In total Mim I Mulford billed 9,336 services in 32 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 552 | 281 | $100.75 | $56K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 489 | 269 | $13.47 | $6,585 |
| 76536 Ultrasound - Nonspecific | Office | 109 | 96 | $95.03 | $10K |
| 99215 Office E&M - Established | Office | 102 | 79 | $139.98 | $14K |
| 95251 Test - Miscellaneous | Office | 46 | 17 | $28.02 | $1,289 |
| 77080 Standard X-ray | Office | 44 | 44 | $44.18 | $1,944 |
| 36415 Venipuncture Blood Collection | Office | 41 | 37 | $8.65 | $355 |
| 84443 Clinical Chemistry | Office | 39 | 36 | $16.46 | $642 |
| 80053 Clinical Chemistry | Office | 38 | 35 | $10.35 | $393 |
| 84439 Clinical Chemistry | Office | 38 | 35 | $8.84 | $336 |
| 83036 Blood Count | Office | 31 | 30 | $9.52 | $295 |
| 80061 Clinical Chemistry | Office | 23 | 23 | $13.12 | $302 |
| 82570 Clinical Chemistry | Office | 12 | 12 | $5.08 | $60.96 |
| 82043 Clinical Chemistry | Office | 12 | 12 | $5.66 | $67.92 |
By year: 2022 $146K for 6,942 services; 2023 $177K for 8,049 services; 2024 $161K for 9,336 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 41 | 37 | $8.65 | $355 |
| 84443 Clinical Chemistry | 39 | 36 | $16.46 | $642 |
| 84439 Clinical Chemistry | 38 | 35 | $8.84 | $336 |
| 80053 Clinical Chemistry | 38 | 35 | $10.35 | $393 |
| 83036 Blood Count | 31 | 30 | $9.52 | $295 |
| 80061 Clinical Chemistry | 23 | 23 | $13.12 | $302 |
| 82043 Clinical Chemistry | 12 | 12 | $5.66 | $67.92 |
| 82570 Clinical Chemistry | 12 | 12 | $5.08 | $60.96 |
Medicare prescription drug claims, 2024
In 2024, the drug Mim I Mulford prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 353 prescriptions and refills. In total Mim I Mulford wrote 1,908 Medicare prescriptions that cost $594K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 353 | 831 | 87 | $35K |
| Levothyroxine Sodium Generic | 166 | 399 | 43 | $1,500 |
| Ozempic Semaglutide | 119 | 154 | 19 | $143K |
| Metformin Hcl Er Metformin Hcl | 102 | 283 | 29 | $945 |
| Alendronate Sodium Generic | 67 | 175 | 19 | $484 |
| Atorvastatin Calcium Generic | 51 | 148 | 17 | $349 |
| Pioglitazone Hcl Generic | 41 | 104 | 11 | $901 |
| Risedronate Sodium Generic | 41 | 74 | Under 11 | $3,114 |
| Methimazole Generic | 38 | 78 | Under 11 | $221 |
| Lisinopril Generic | 37 | 84 | Under 11 | $131 |
| Metformin Hcl Generic | 36 | 102 | 14 | $427 |
| Liothyronine Sodium Generic | 36 | 91 | 11 | $1,349 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 34 | 83 | Under 11 | $6,765 |
| Januvia Sitagliptin Phosphate | 33 | 75 | Under 11 | $40K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 32 | 68 | Under 11 | $1,982 |
Brand drugs: 906 claims; generic drugs: 929 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mim I Mulford $1,676 ($1,676 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $146.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $146 |
| Novo Nordisk Inc NVO | 6 | $139 |
| Amgen Inc. AMGN | 7 | $123 |
| Insulet Corporation PODD | 3 | $104 |
| Abbott Laboratories ABT | 4 | $98.36 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $93.33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90.71 |
| Recordati_rare_diseases_inc. | 3 | $86.07 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $74.42 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $67.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.